Clinical Trial Update: A Clinical Study of KLH-2109 in Uterine Fibroids Patient With Menorrhagia [Phase 3]

View source ↗

Summary

This document reports a Phase 3 clinical trial of KLH-2109 for uterine fibroids with menorrhagia. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• KLH-2109

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Uterine Fibroids (MeSH Heading: Leiomyoma) | Phase 3 | Status: COMPLETED